Can Pluristem Therapeutics Corner the Acute Radiation Syndrome Market?

Company may become a major player in the ARS game

Author's Avatar
Apr 11, 2017
Article's Main Image

I am long PSTI and may purchase additional shares within the next 72 hours.

[This article was originally featured on CNA Finance]